CY1108945T1 - Παραγωγα πεπτιδιων και πεπτιδομιμητικων ενωσεων με ιδιοτητες αναστολεα ενσωματινης ιι - Google Patents

Παραγωγα πεπτιδιων και πεπτιδομιμητικων ενωσεων με ιδιοτητες αναστολεα ενσωματινης ιι

Info

Publication number
CY1108945T1
CY1108945T1 CY20091100374T CY091100374T CY1108945T1 CY 1108945 T1 CY1108945 T1 CY 1108945T1 CY 20091100374 T CY20091100374 T CY 20091100374T CY 091100374 T CY091100374 T CY 091100374T CY 1108945 T1 CY1108945 T1 CY 1108945T1
Authority
CY
Cyprus
Prior art keywords
arg
lys
sup
gln
ile
Prior art date
Application number
CY20091100374T
Other languages
English (en)
Inventor
Jörg Meyer
Berthold Nies
Michel Dard
Günter Hölzemann
Horst Kessler
Martin Kantlehner
Ulrich Hersel
Christoph Gibson
Gabor Sulyok
Original Assignee
Biomet Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomet Deutschland Gmbh filed Critical Biomet Deutschland Gmbh
Publication of CY1108945T1 publication Critical patent/CY1108945T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/10—Process efficiency

Abstract

Ενώσεις του τύπου (I): B-Q-X1, όπου Β σημαίνει βιοενεργό μόριο που μεσολαβεί στην κυτταρική προσκόλληση, επιλεγόμενο από την ομάδα (i) και Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (ii), Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iii), Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iv), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg (v), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn (vi), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg (vii), όπου για (i) Χ, Υ, Ζ, R2, R3, R4, A, Ar, Hal, Het, Het1, n, m, o, p, q, s, t έχουν τις σημασίες που δίδονται στην αξίωση 1, Q είναι απούσα ή είναι οργανικό διαχωριστικό μόριο, Χ1 είναι μόριο αγκίστρωσης, επιλεγόμενο από την ομάδα που δίδεται στην αξίωση 1, καθώς και άλατα αυτών, μπορούν να χρησιμοποιηθούν ως αναστολείς ενσωματίνης, ιδίως για την αγωγή παθήσεων, ατελειών, φλεγμονών προκαλούμενων από εμφυτεύματα και οστεολυτικών παθήσεων όπως οστεοπόρωσης, θρόμβωσης, καρδιακού εμφράγματος και αρτηριοσκλήρυνσης, καθώς και για την επιτάχυνση και ενίσχυση της διεργασίας ολοκλήρωσης του εμφυτεύματος ή της βιοσυμβατικής επιφάνειας στον ιστό.
CY20091100374T 2000-08-17 2009-03-31 Παραγωγα πεπτιδιων και πεπτιδομιμητικων ενωσεων με ιδιοτητες αναστολεα ενσωματινης ιι CY1108945T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040103A DE10040103A1 (de) 2000-08-17 2000-08-17 Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II
EP01960611A EP1309610B1 (de) 2000-08-17 2001-08-02 Peptid- und peptidmimetika-derivate mit integrin-inhibitor-eigenschaften ii

Publications (1)

Publication Number Publication Date
CY1108945T1 true CY1108945T1 (el) 2014-07-02

Family

ID=7652667

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100374T CY1108945T1 (el) 2000-08-17 2009-03-31 Παραγωγα πεπτιδιων και πεπτιδομιμητικων ενωσεων με ιδιοτητες αναστολεα ενσωματινης ιι

Country Status (17)

Country Link
US (1) US7276482B2 (el)
EP (1) EP1309610B1 (el)
JP (1) JP4795620B2 (el)
KR (1) KR20030062318A (el)
CN (1) CN1446230A (el)
AT (1) ATE419269T1 (el)
AU (1) AU2001282058A1 (el)
CA (1) CA2419469C (el)
CY (1) CY1108945T1 (el)
CZ (1) CZ2003719A3 (el)
DE (2) DE10040103A1 (el)
DK (1) DK1309610T3 (el)
ES (1) ES2317926T3 (el)
MX (1) MXPA03001427A (el)
PL (1) PL366312A1 (el)
PT (1) PT1309610E (el)
WO (1) WO2002014350A2 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001221607A1 (en) 2000-11-20 2002-05-27 Ecole Polytechnique Federale De Lausanne (Epfl) Endosseous implant
DE10325049A1 (de) * 2003-06-02 2004-12-23 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012727A1 (en) * 1991-01-25 1992-08-06 Regents Of The University Of Minnesota Laminin a chain domain vi polypeptides
DE19755801A1 (de) * 1997-12-16 2000-06-21 Merck Patent Gmbh Mit die Zelladhäsion vermittelnden Peptiden beschichtete Implantate und Verfahren zu ihrer Herstellung
US6280760B1 (en) * 1997-05-22 2001-08-28 Merck Patent Gesellschaft Mit Beschraenkter Haftung Peptide-coated implants and methods for producing same
DE19755800A1 (de) * 1997-12-16 1999-06-17 Merck Patent Gmbh Cyclopeptidderivate
DE19831710A1 (de) 1998-07-15 2000-01-20 Merck Patent Gmbh Diacylhydrazinderivate
DE19932796A1 (de) 1999-07-14 2001-01-18 Merck Patent Gmbh Diacylhydrazinderivate

Also Published As

Publication number Publication date
PL366312A1 (en) 2005-01-24
WO2002014350A2 (de) 2002-02-21
DK1309610T3 (da) 2009-03-30
MXPA03001427A (es) 2003-06-06
AU2001282058A1 (en) 2002-02-25
JP2004506649A (ja) 2004-03-04
CZ2003719A3 (cs) 2003-06-18
WO2002014350A3 (de) 2002-09-19
PT1309610E (pt) 2009-03-16
JP4795620B2 (ja) 2011-10-19
CA2419469A1 (en) 2003-02-14
US7276482B2 (en) 2007-10-02
CN1446230A (zh) 2003-10-01
DE10040103A1 (de) 2002-02-28
EP1309610B1 (de) 2008-12-31
DE50114621D1 (de) 2009-02-12
EP1309610A2 (de) 2003-05-14
ATE419269T1 (de) 2009-01-15
KR20030062318A (ko) 2003-07-23
ES2317926T3 (es) 2009-05-01
CA2419469C (en) 2013-05-14
US20040043937A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
Pampena et al. Inhibition of hydroxyapatite formation by osteopontin phosphopeptides
NO20052493L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO933248L (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
NO986090L (no) Fenylalaninderivater som integrininhibitorer
NO20065178L (no) Tienopyridinderivater
MY129408A (en) Disubstituted bicyclic, heterocycles, the preparation and the use thereof as pharmaceutical compositions
DE60130023D1 (de) Behandlung der nebenwirkungen von statinen
BR0113472A (pt) Macrolìdeos com atividade antibacteriana
SI0773943T1 (en) Compounds useful as antiproliferative agents and garft inhibitors
DE602004026095D1 (de) Chinoloncarbonsäureverbindungen mit 5-ht4-rezeptoragonistischer wirkung
ATE395085T1 (de) Peptid- und peptidmimetikakonjugate mit integrin- inhibitor-eigenschaften
CY1108945T1 (el) Παραγωγα πεπτιδιων και πεπτιδομιμητικων ενωσεων με ιδιοτητες αναστολεα ενσωματινης ιι
NO20022232L (no) Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII
ATE273285T1 (de) Neue guanidin-derivate als zelladhäsion- inhibitoren
DE69832376D1 (de) 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten
AU2003274686A1 (en) Inhibitors of the gpib -vwf interaction, their preparation and use
WO2000039087A3 (en) Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
CA2234980A1 (en) Cyclopeptide derivatives
US11492382B2 (en) Chimeric peptides with an antimicrobial domain and an inorganic binding domain
ATE409499T1 (de) Verwendung von antiseptischen wirkstoffen in pmma-knochenzementen
EA200200122A1 (ru) Производные нафтиридина, способ их получения, их применение и содержащие их фармацевтические композиции
NO20020885L (no) <alfa>v<beta>3-integrininhibitorer
NO20014130L (no) Epitoper eller mimotoper avledet fra C-<epsilon>2-domenet hos IgE, antagonister derav og deres terapeutiske anvendelser
YU33900A (sh) Derivati ehinokandina, postupak za njihovo dobijanje i njihova primena kao anti-fungocida
PL322969A1 (en) Substituted phenylamidines, pharmaceutic compositions containing theses compounds and method of obtaining them